Media Thread, page-10517

Thanks@GMT2

Great interview from Leslie. A must see for all investors. Thank you for posting.

Coming home with a wet sail now. So much to look forward to.

Now Vaxinia has shown positive signals at relatively low doses immeasurable value can be attributed to the other recipients in the IMU food chain, namely Oncarlytics and azure cel, both currently in trial.Light is at the end of the tunnel for all those possessing the courage and tenacity, (if not resilience), to go the distance with Imugene.

If IMU wasn't already on the radar of CAR T providers, Big Pharma and major healthcare investors, it certainly shall be now. I'd be messaging Bake Brothers if I was on the team.

DYOR